-
-
Call more information
660-596-2224 -
Authors: Bailor L. Hardman, MD et al ASA Monitor April 2022, Vol. 86, 42. Rocuronium is a non-depolarizing muscle relaxant that was first introduced in 1994, and its development ultimately replaced another aminosteroid neuromuscular blocking drug, vecuronium. Rocuronium is a monoquaternary amine with a rapid onset and intermediate duration of action. It is six to eight […]
Read MoreAuthors: Jennifer W. He, B.MSc. et al Anesthesiology April 2022, Vol. 136, 577–587. Background Intraabdominal surgeries are frequently performed procedures that lead to a high volume of unplanned readmissions and postoperative complications. Patient sex may be a determinant of adverse outcomes in this population, possibly due to differences in biology or care delivery, but it is […]
Read MoreAuthors: Philip Bickler, M.D., Ph.D. and Kevin K. Tremper, Ph.D., M.D. Anesthesiology May 2022, Vol. 136, 670–671. It is amazing to think that a device developed for aviation research during World War II and implemented into anesthesia care in the mid-1980s is now likely the most common medical device on Earth—with the possible exception of the thermometer. […]
Read MoreAuthor: Richard Novak, MD The Anesthesia Consultant What is a difficult anesthetic? Most people have no real idea what anesthesiologists do. Many imagine an anesthesiologist’s job is to give a patient some “gas” which to keep the patient asleep, while the surgeon (the real doctor) heals the patient. This image is oversimplified and wrong. Anesthesiologists […]
Read MoreAuthors: Nicolas Nesseler, M.D., Ph.D. et et Anesthesiology May 2022, Vol. 136, 732–748. Background Despite expanding use, knowledge on extracorporeal membrane oxygenation support during the COVID-19 pandemic remains limited. The objective was to report characteristics, management, and outcomes of patients receiving extracorporeal membrane oxygenation with a diagnosis of COVID-19 in France and to identify pre-extracorporeal membrane […]
Read More